Expression of ERBB Family Members as Predictive Markers of Prostate Cancer Progression and Mortality

SIMPLE SUMMARY: Patients diagnosed with prostate cancer are usually offered a standard treatment plan based on their Gleason score, stage, and prostate-specific antigen (PSA) level. However, studies on other cancers have shown the importance of using biomarkers in addition to clinical and pathologic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Clairefond, Sylvie, Ouellet, Véronique, Péant, Benjamin, Barrès, Véronique, Karakiewicz, Pierre I., Mes-Masson, Anne-Marie, Saad, Fred
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8038288/
https://ncbi.nlm.nih.gov/pubmed/33918389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071688
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky